GLSI · Greenwich LifeSciences, Inc. · Investor Relations
$18.75
-0.24 (-1.26%)
At close · Sep 21
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has prepared its financial statements on a going concern basis, which assumes that the Company will realize its assets and satisfy its liabilities in the normal course of business. However, the Company has incurred net losses since its inception and has negative operating cash flows. These circumstances raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these financial statements are issued.”View the 10-Q filed Aug 11, 2026
Market Cap
$269.93M
Shares
14.68M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-04-21 | AACR Meeting | Event |
| 2025-12-03 | Fireside Chat with Research Analyst at Noble Conference on December 3, 2025 | Conference |
| 2025-06-28 | Interview on Bloomberg TV on June 28, 2025 | Event |